Editorial [Hot Topic: Regulation of Glutamate Synthesis Via Inhibition of Glutamate Carboxypeptidase II (GCPII): An Effective Method to Treat Central and Peripheral Nervous System Disorders (Guest Editors: Guido Cavaletti and Barbara Slusher)]

By  

Current Medicinal Chemistry, Vol. 19, Iss. 9, 2012-01 ,pp. : 1259-1260

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-

By Thomas A.G.   Liu W.   Olkowski J.L.   Tang Z.   Lin Q.   Lu X.-C.M.   Slusher B.S.  

European Journal of Pharmacology, Vol. 430, Iss. 1, 2001-10 ,pp. : 33-40

Elsevier

Access to resources Recommend Favorite

Structure-Activity Relationships of Glutamate Carboxypeptidase II (GCPII) Inhibitors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 9, 2012-03 ,pp. : 1282-1294

Bentham Science Publishers

Access to resources Recommend Favorite

The potential use of carboxypeptidase G₂ in the treatment of cancer

By Burke P.J.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 2, 2000-02 ,pp. : 209-214

Informa Healthcare

Access to resources Recommend Favorite

The Role of Glutamate in Diabetic and in Chemotherapy Induced Peripheral Neuropathies and its Regulation by Glutamate Carboxypeptidase II

By  

Current Medicinal Chemistry, Vol. 19, Iss. 9, 2012-03 ,pp. : 1261-1268

Bentham Science Publishers

Access to resources Recommend Favorite